علاج التهاب الرئة التحسسي غير الليفي

References

DOI: 10.1183/16000617.0169-2021

Patients with HP may be categorised as having non-fibrotic or fibrotic HP.

In cases of non-fibrotic HP where the inciting antigen has been removed and lung function is not severely impaired, it may be appropriate not to initiate therapy but to ensure the patient is closely monitored.

Corticosteroids should be considered in patients with severe lung function impairment or progressive disease.

HP may initially respond to corticosteroids, but there is little evidence that corticosteroids provide a long-term benefit or slow the progression of fibrotic HP.